CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ATYRaTYR PHARMA INC

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $0.30 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$29.72M
CountryUSA
RECENT INSIDER TRADES
  • 2026-05-28 · SCHIMMEL PAUL (Director) · BUY
  • 2026-02-04 · Broadfoot Jill Marie (Chief Financial Officer) · SELL
  • 2026-02-04 · DENYES NANCY (General Counsel) · SELL
  • 2026-02-04 · Shukla Sanjay (President and CEO) · SELL
  • 2025-10-09 · SCHIMMEL PAUL (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders97
Shares held46,995,619
Value$29.50M
Percent of shares outstanding47.91%
As of quarter end2026-06-30
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
aTYR PHARMA INC (ATYR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit